鹅感染多杀性巴氏杆菌和大肠杆菌的分离鉴定

某地一鹅群发生一种以败血、高死亡率为特征的急性传染病．其临床表现为沉郁、不食、下痢等。病变特征以内脏器官充血、出血和坏死为主。本文从鹅体内分离到16株细菌．经鉴定为多杀性巴氏杆菌和大肠杆菌混合感染；并进行了毒力试验和药敏试验，结果表明多杀性巴氏杆菌致病性较强．大肠杆菌致病性稍弱．两菌混合感染致病性最强。恩诺沙星、单诺沙星和头孢氨苄西林对两种菌均为高敏。其余药物为中敏或不敏感。     

鸡感染多杀性巴氏杆菌和大肠杆菌的分离鉴定

本研究从鸡体内分离到16株细菌,经鉴定为多杀性巴氏杆菌和大肠杆菌混合感染。毒力试验和药敏试验的结果表明,多杀性巴氏杆菌致病性较强,大肠杆菌致病性稍弱,2菌混合感染致病性最强;恩诺沙星、单诺沙星和头孢氨苄西林对两种菌均为高敏,其余药物为中敏或不敏感。     

D型多杀性巴氏杆菌和绵羊肺炎支原体引起山羊的混合感染

2018年9月广西某羊场部分山羊发生流涕、咳嗽、呼吸困难和体温升高等临床症状的疾病,为确诊发病原因并提供治疗方案,采用病原分离培养、PCR扩增鉴定的方法进行诊断,并对分离菌进行生化鉴定、致病性试验和药敏试验。结果显示,病料在血平板有圆形的小菌落生长,革兰阴性小球短杆菌,而在PPLO培养基上不生长;病料的PCR扩增结果显示绵羊肺炎支原体和多杀性巴氏杆菌均为阳性;所分离到的病原菌经生化鉴定,该菌符合多杀性巴氏杆菌的特性;用多杀性巴氏杆菌种属和D型多杀性巴氏杆菌特异性引物扩增为阳性;致病性试验显示该菌对小鼠有很强的致病性;药敏试验显示该菌对头孢他啶、头孢噻肟、氧氟沙星高度敏感,对复方新诺明、强力霉素、红霉素、青霉素为耐药。结果表明该病是由绵羊肺炎支原体和D型多杀性巴氏杆菌混合感染引起。     

禽多杀性巴氏杆菌ptfa基因PCR检测方法的初步建立

为建立一种禽多杀性巴氏杆菌的PCR检测方法,本研究根据GenBank中已发表的禽多杀性巴氏杆菌ptfa基因序列,设计与合成了一对特异性引物,建立了一种基于禽多杀性巴氏杆菌ptfa基因的PCR检测方法,并优化了反应条件,检测了该方法的特异性和敏感性。结果显示,该方法可成功扩增出禽多杀性巴氏杆菌ptfa基因片段,而鸡致病性大肠杆菌、鸡金黄色葡萄球菌和鸡白痢沙门菌均未扩增出相应片段。敏感性试验表明该方法可检测最低浓度为1pg/μL的禽多杀性巴氏杆菌基因组DNA。     

猪源多杀性巴氏杆菌的分离鉴定及其荚膜血清型鉴定

从病死母猪肺脏中分离到一株革兰氏阴性小杆菌,用生理生化鉴定、药敏试验、致病性试验和PCR鉴定方法对分离菌株进行鉴定,并用多杀性巴氏杆菌荚膜分型引物对分离株的荚膜血清型进行鉴定。结果表明:本菌为猪多杀性巴氏杆菌,对多种抗生素高度敏感,对小白鼠有强致病性;PCR扩增16SrDNA基因获得1415bp片段,分离株的16SrDNA核苷酸序列与多杀性巴氏杆菌(AY078999)的同源性为99%,因此该分离菌株被鉴定为致病性巴氏杆菌,命名为YN20110122株;本菌分离株为荚膜A型血清型多杀性巴氏杆菌。     

10日龄肉鸭混合感染新型鸭肝炎病毒和多杀性巴氏杆菌的病原学研究

对1例疑似鸭肝炎病毒和多杀性巴氏杆菌混合感染的10日龄肉鸭采用常规的病毒、细菌鉴定方法和RT-PCR、PCR方法分别进行病毒、细菌的分离与鉴定。病毒鉴定为新型鸭肝炎病毒,细菌鉴定为荚膜血清A型多杀性巴氏杆菌多杀亚种。细菌对SPF鸡的毒力试验结果显示,分离的巴氏杆菌与强毒标准株C48-1毒力相近,为强毒株。细菌对10日龄肉鸭的致病性回归试验结果表明,一定数量的该株巴氏杆菌可导致10日龄雏鸭的感染死亡。结果表明,该批肉鸭为新型鸭肝炎病毒和A型多杀性巴氏杆菌混合感染。这是国内首例从感染鸭肝炎病毒10日龄雏鸭肝脏中分离到多杀性巴氏杆菌。     

77株鸡致病菌对19种抗菌药物的敏感性试验

对从广东不同地区的养鸡场分离的７７株致病性大肠杆菌、沙门氏杆菌、禽多杀性巴氏杆菌和绿脓杆菌用１９种抗菌药物进行了敏感性试验。结果表明,４种试验菌对头孢氨苄、新霉素、环丙沙星和诺氟沙星的敏感度较高,禽多杀性巴氏杆菌和绿脓杆菌对庆大霉素,依诺沙星也较敏感。以上药物可作为防治这４种细菌病的首选药物。     

梅花鹿巴氏杆菌与大肠杆菌混合感染的诊断与防治

梅花鹿巴氏杆菌病是由多杀性巴氏杆菌所引起的一种传染病。本病以败血症和炎性出血过程为主要特征的传染病,故本病又称出血性败血症。本病对梅花鹿危害最大,可致鹿只死亡,造成巨大经济损失。大肠杆菌病是由大肠杆菌引起的一种急性传染病。其特征是严重腹泻和发生败血症。笔者对我县一梅花鹿场发生的鹿巴氏杆菌与大肠杆菌混合感染的诊断与防治作如下报告。     

猪鸡交互感染巴氏杆菌病的报导

巴氏杆菌病主要是由多杀性巴氏杆菌所引起的各种家畜、家禽和野生动物的一种传染病。多杀性巴氏杆菌对人也有致病性。关于巴氏杆菌在同种畜(禽)相互感染问题,说法都大同小异,而对巴氏秆菌在畜、禽之间相互感染问题,却是语焉不详。关于巴氏杆菌病在畜、禽之间的交互感染的介绍和报道极为少见。为了丰富这方面的资料,我们将猪、鸡交互感染巴氏杆菌病一例报道于     

奶牛多杀性巴氏杆菌和肺炎克雷伯氏菌混合感染的实验室诊断

2019年9月,黑龙江省绥化市青冈县某牛场发生一起以奶牛出现体温升高、呼吸困难、不食、流涎、急性胃肠炎和急性死亡为特征的传染病,发病率为31%,病死率为51%,发病牛产奶量急剧下降,经济损失惨重,结合临床诊断和病理解剖、实验室诊断,确诊为多杀性巴氏杆菌和克雷伯氏菌混合感染。药敏试验结果显示,硫酸链霉素、硫酸庆大霉素对多杀氏巴氏杆菌和克雷伯氏菌高度敏感,可用于该病治疗。     

Bovine pneumonic pasteurellosis: chemiluminescent response of bovine peripheral blood leukocytes to living and killed Pasteurella haemolytica, Pasteurella multocida, and Escherichia coli

A luminol-dependent chemiluminescence (LDCL) assay was used to evaluate the response of bovine polymorphonuclear leukocytes; (neutrophils [PMN]) to living and heat-killed Escherichia coli, Pasteurella multocida (type A, serotype 3), and P haemolytica (biotype A, serotype 1), and to heat-killed P haemolytica and sterile culture supernatant from living P haemolytica. Control cultures containing PMN that had not been phagocytically stimulated with bacteria had a modest increase in LDCL during the initial 10 minutes of incubation, followed by a gradual decline throughout the 120-minute incubation period. Bovine PMN emitted LDCL more efficiently when the cells were exposed to living E coli or P multocida than when they were exposed to the same bacteria killed by heat. The mean LDCL values for reaction mixtures containing living E coli or P multocida peaked at 30 minutes of incubation and remained above values for mixtures containing the same heat-killed bacteria. Kinetics of the LDCL response of bovine PMN to heat-killed P haemolytica were similar (although reduced in amplitude) to that observed with killed E coli or P multocida. The LDCL response of bovine PMN to living P haemolytica was not like that for E coli or P multocida, and was characterized by the development of a peak response at 10 minutes followed by a precipitous decrease in responsiveness and a subsequent complete cessation of LDCL. Addition of sterile culture supernatant from living P haemolytica to test samples containing heat-killed P haemolytica induced a response similar to that obtained with the living microorganism.(ABSTRACT TRUNCATED AT 250 WORDS)     

Turkey macrophage and heterophil bactericidal activity against Pasteurella multocida.

Bactericidal activity of turkey macrophages and heterophils was demonstrated in an in vitro colorimetric bactericidal assay. Two vaccine strains and one field isolate of Pasteurella multocida A:3,4 and a single isolate each of Escherichia coli and Staphylococcus aureus were compared for susceptibility to the bactericidal activity of turkey macrophages and heterophils. Only P. multocida A:3,4-strain M-9 (the least virulent strain) was susceptible to macrophage bactericidal activity in the absence of specific immune serum, whereas all three P. multocida A:3,4 organisms were killed when opsonized with specific immune serum. E. coli was susceptible to the bactericidal activity of macrophages, and S. aureus was resistant. All bacteria tested were highly sensitive to the bactericidal activity of intact turkey heterophils, regardless of the opsonin treatment. Electron microscopic findings suggested that heterophils may kill extracellular P. multocida. Only S. aureus and E. coli were killed by lysed heterophils.     

Pasteurella multocida-associated sinusitis in khaki Campbell ducks (Anas platyrhynchos)

Pasteurella multocida group B, serotype 3, was isolated from sinusitis-affected khaki Campbell ducks. To study the role of P. multocida in sinusitis, commercial khaki Campbell ducks were experimentally infected with P. multocida alone or combined with Escherichia coli. In Expt. 1, experimental ducks were infected with P. multocida intranasally or ocularly. A comparison was done by intranasal inoculation with pooled nasal discharge from the affected ducks or phosphate-buffered saline. The ducks intranasally inoculated with the nasal discharge or P. multocida showed sinusitis. In Expt. 2, E. coli alone or a combination of P. multocida and E. coli was intranasally inoculated into experimental ducks. The ducks intranasally inoculated with the combination of P. multocida and E. coli had sinusitis, the same as found in the field but less severe than that of the field cases. Pasteurella multocida was already present in litter/floor of duck farms. We concluded that P. multocida played a role in induction of sinusitis. However, the sinusitis in ducks may be initiated by poor management, especially in the brooding period of ducks.     

In vitro susceptibility of avian Escherichia coli and Pasteurella multocida to danofloxacin and five other antimicrobials.

The in vitro susceptibility of Escherichia coli and Pasteurella multocida isolated from poultry was determined to danofloxacin, a novel fluoroquinolone, and five other commonly used antimicrobials. A total of 1737 E. coli field isolates and 107 P. multocida isolates were tested by veterinary diagnostic laboratories in Europe, Japan, South Africa, and North America during the period 1989-91. The antimicrobial susceptibility of these isolates was determined using the Sensititre broth microdilution technique. The minimum inhibitory concentrations (MIC) of danofloxacin, furaltadone, lincomycin, oxytetracycline, spectinomycin, and trimethoprim:sulfamethoxazole that prevented growth of 90% of the bacteria were 0.25 > 64, > 64, > 64, > 128, and > 16 micrograms/ml, respectively, against E. coli isolates and 0.25, 64, 64, 16, 128, and 8 micrograms/ml, respectively, against P. multocida isolates. Danofloxacin demonstrated considerable in vitro potency against these important poultry pathogens, many of which showed extensive resistance to the other antimicrobials tested.     

Cloning and characterisation of the ahpA gene of Pasteurella multocida serogroup b:2 (strain P52): short communication

Pasteurella multocida B:2 is responsible for haemorrhagic septicaemia in cattle and buffaloes, causing severe economic losses in the developing countries. In the present study, the ahpA gene of P. multocida B:2 (P52) was cloned, sequenced and compared with the previously reported ahpA gene sequence in P. multocida A:1, which is responsible for its haemolytic phenotype. E. coli DH5a cells were further transformed with recombinant plasmid carrying the ahpA gene from P. multocida B:2 (P52) but SDS-PAGE analysis failed to show the expression of haemolysin protein. Slight haemolysis was albeit observed in horse blood agar plates streaked with recombinant E. coli carrying the ahpA gene. Our study indicates that there is 99.6% similarity and 0.4% divergence between ahpA gene of P. multocida B:2 (P52) and P. multocida A: 1, while membrane topology analysis has predicted that ahpA is an inner membrane protein with two strong hydrophobic regions at the N and C terminals. The presence of significant homology in ahpA sequence in A: 1 and B:2 perhaps suggests a common mechanism of pathogenesis in different species of animals.     

牛多杀性巴氏杆菌外膜蛋白H的表达与纯化

试验对多杀性巴氏杆菌外膜蛋白H(OmpH)基因进行克隆、鉴定,并在原核系统中表达。以多杀性巴氏杆菌(CVCC448)强毒株基因组为模板,扩增OmpH基因,连接T载体,经测序鉴定正确后与表达载体pET-28a连接构建重组表达质粒OmpH-pET28a,将此重组质粒转化入表达宿主E.coli BL21菌株内,抽提质粒,酶切鉴定正确后对转化菌株以IPTG进行诱导,表达产物通过镍离子亲和层析纯化,之后进行SDS-PAGE和Western blotting分析。结果显示,OmpH基因的编码区为978 bp,编码326 个氨基酸残基,融合蛋白分子质量约为37 ku。Western blotting检测结果显示,表达的重组蛋白OmpH可与鼠抗多杀性巴氏杆菌全菌体多抗血清反应得到清晰的目的条带,表明表达的重组蛋白具有良好的免疫原性。多杀性巴氏杆菌OmpH基因的成功表达,为进一步研究其免疫作用奠定了基础。     

产毒素多杀性巴氏杆菌菌落双重PCR检测方法的建立

为建立快速特异的PCR方法以及同时检测并区分产毒素与非产毒素多杀性巴氏杆菌,本研究根据GenBank登录的多杀性巴氏杆菌KMT1基因和toxA毒素基因序列,设计合成了2对特异引物。特异性试验表明产毒素多杀性巴氏杆菌C51-6扩增出了460bp和1854bp的2条目的片段,而不产毒素多杀性巴氏杆菌、大肠埃希菌、胸膜肺炎放线杆菌、猪链球菌、支气管败血波氏杆菌、副猪嗜血杆菌和鸡白痢沙门菌的扩增均为阴性;敏感性试验表明该PCR方法能从含450CFU的菌液中扩增出相应的目的片段。同时用豚鼠皮肤坏死试验和小鼠致死试验对该PCR方法进行了验证。     

Overexpression and immunogenicity of the Oma87 outer membrane protein of Pasteurella multocida

The outer membrane protein of Oma87 from Pasteurella multocida A:1 has significant similarity to the D15 protective antigen of Haemophilus influenzae (Ruffolo and Adler, 1996). Four fragments of Oma87 from a P. multocida serotype D strain were cloned into a pGEX expression vector and transformed into E. coli JM105. Western blot analysis revealed that convalescent chicken sera reacted with only GST-F1 fusion protein which contained amino acids 18 through to 130 of Oma87 fused to the GST protein. Vaccination with the GST-F1 protein failed to protect chickens against challenge with a virulent P. multocida serotype A.     

Evaluation of commercially available Escherichia coli J5 bacterin as protection against experimental challenge with Pasteurella multocida in rabbits.

OBJECTIVE: To evaluate the ability of commercially available Escherichia coli J5 bacterin to protect rabbits from experimental challenge with Pasteurella multocida. ANIMALS: 40 P multocida-free New Zealand White rabbits. PROCEDURES: Rabbits were assigned to 1 of 4 groups of 10 rabbits each. Three of the groups were inoculated SC with J5 bacterin at 8 weeks old. Inoculation was repeated 3 and 6 weeks later. The fourth group was not inoculated and served as controls. Groups 1, 2, and 3 were given 10(9), 10(8), and 10(7) colony forming units (CFU), respectively. Response was monitored by titer assessment, using an E coli J5 antigen capture ELISA. Five weeks after the last inoculation, all rabbits were challenged with P multocida and observed for an additional 5 weeks. Clinical, hematologic, serologic, culture, and necropsy data were collected. RESULTS: Inoculation of rabbits with 10(9) CFU of E coli J5 bacterin-induced titers that were significantly greater than titers of rabbits vaccinated with 10(8) or 10(7) CFU or those in controls. The incidence of acute bacteremia was lower in rabbits with high titers. At necropsy, prevalence of lesions typical of P multocida was not significantly different among groups. Prevalence of histologic lesions was also not significantly different among groups. CONCLUSIONS AND CLINICAL RELEVANCE: Although the bacterin induced considerable antibody response and possibly reduced the rate of bacteremia, antibodies were not protective against long-term colonization or infection of the frontal sinuses or tympanic bullae by the challenge strain of P multocida. This bacterin in its currently available form is unlikely to aid in reducing the prevalence of pasteurellosis in rabbits.     

兔巴氏杆菌和波氏杆菌多重PCR检测方法的建立

参考GenBank中兔巴氏杆菌16SrRNA和波氏杆菌的fim2的基因序列,应用Premier 5.0软件在二者高度保守区设计了2对引物,建立了适合巴氏杆菌和波氏杆菌快速检测的多重PCR检测方法。以该方法对巴氏杆菌和波氏杆菌参考菌株进行PCR扩增,分别能从各自的基因组中扩增出与试验设计相符的644bp和425bp的特异性DNA片段。将扩增所得的DNA片段进行克隆测序,测序结果表明分别为巴氏杆菌16SrRNA和波氏杆菌fim2基因序列。该方法对波氏杆菌的检测下限为4×102 CFU,对巴氏杆菌的检测下限为6×101 CFU。对兔源性沙门菌、葡萄球菌、大肠杆菌、魏氏梭菌扩增结果为阴性。表明所建立的RT-PCR检测技术具有特异、快速和敏感的特点,可用于鉴别诊断兔巴氏杆菌和波氏杆菌以及2者混合感染。